Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain

被引:14
作者
Bundgaard, H
Havndrup, O
Andersen, PS
Larsen, LA
Brandt, NJ
Vuust, J
Kjeldsen, K
Christiansen, M
机构
[1] Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen S, Denmark
[2] Univ Copenhagen, Rigshosp, Ctr Heart, Dept Med B2141, Copenhagen, Denmark
关键词
hypertrophic cardiomyopathy; sudden cardiac death; mutation detection; PCR-SSCP; myosin structure and function; ATP binding;
D O I
10.1006/jmcc.1998.0911
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mutations in the cardiac beta-myosin heavy chain gene (MYH7), and other genes encoding cardiac sarcomere proteins may cause familial hypertrophic cardiomyopathy (F-HCM), an autosomal dominant disease, characterized by myocardial hypertrophy. We analysed the MYH7 gene in three generations of a family with one borderline and four clinically verified cases of hypertrophic cardiomyopathy, and identified a mutation in exon 7 changing the 190 arginine residue into a threonine residue. The mutation is located in the ATP-binding region of the myosin head and alters the charge in the F-helix close to the phosphate-binding P-loop. The mutation may thus interfere with the coupling between ATP-hyrolysis and the transition into mechanical energy. In conclusion, the novel Arg190Thr mutation in exon 7 of the MYH7 gene is associated with the development of symptomatic myocardial hypertrophy in adults. (C) 1999 Academic Press.
引用
收藏
页码:745 / 750
页数:6
相关论文
共 36 条
  • [31] A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy
    Hitomi, Nobuhiko
    Kubo, Toru
    Kitaoka, Hiroaki
    Hirota, Takayoshi
    Hamada, Tomoyuki
    Hoshikawa, Eri
    Hayato, Kayo
    Okawa, Makoto
    Kimura, Akinori
    Doi, Yoshinori L.
    JOURNAL OF CARDIOLOGY, 2010, 56 (02) : 189 - 196
  • [32] GENOTYPE-PHENOTYPE CORRELATIONS IN HYPERTROPHIC CARDIOMYOPATHY - INSIGHTS PROVIDED BY COMPARISONS OF KINDREDS WITH DISTINCT AND IDENTICAL BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS
    FANANAPAZIR, L
    EPSTEIN, ND
    CIRCULATION, 1994, 89 (01) : 22 - 32
  • [33] A molecular screening strategy based on β-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy
    Girolami, Francesca
    Olivotto, Iacopo
    Passerini, Ilaria
    Zachara, Elisabetta
    Nistri, Stefano
    Re, Federica
    Fantini, Silvia
    Baldini, Katia
    Torricelli, Francesca
    Cecchi, Franco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2006, 7 (08) : 601 - 607
  • [34] Homozygosity for a novel splice site mutation in the cardiac myosin-binding protein c gene causes severe neonatal hypertrophic cardiomyopathy
    Xin, Baozhong
    Puffenberger, Erik
    Tumbush, John
    Bockoven, J. R.
    Wang, Heng
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2007, 143A (22) : 2662 - 2667
  • [35] A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death
    Konno, T
    Shimizu, M
    Ino, H
    Fujino, N
    Uchiyama, K
    Mabuchi, T
    Sakata, K
    Kaneda, T
    Fujita, T
    Masuta, E
    Mabuchi, H
    CLINICAL SCIENCE, 2006, 110 (01) : 125 - 131
  • [36] Beta-myosin heavy-chain mutations R403QLW, V606M, K615N and R663H in patients with hypertrophic cardiomyopathy
    Atay, Sevcan
    Tetik, Asli
    Cetintas, Vildan Bozok
    Tuluce, Selcen Yakar
    Tuluce, Kamil
    Kayikcioglu, Meral
    Eroglu, Zuhal
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2014, 14 (03) : 244 - 250